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1. Introduction
1.1. Reactive oxygen species: An overview
Oxygen free radicals or, more generally, reactive oxygen species (ROS) are products of normal
cellular metabolism. They are well recognized for playing a contradictory dual role in living
systems, sometimes deleterious sometimes beneficial, depending on cell type, genetic back‐
ground and levels and types of species involved. Beneficial effects of ROS occur at low/
moderate concentrations and involve modulation of signaling pathways and gene expression
regulation. The harmful effect of free radicals is termed oxidative stress and can result in
damage to cellular lipids, proteins and DNA. The balance between benign and deleterious
effects of ROS is a decisive factor of living organisms and is controlled by mechanisms called
redox regulation. This process protects cells from oxidative stress and maintains the redox
homeostasis by modulating the redox state in vivo [17].
ROS are a group of chemically reactive molecules derived from partial reduction of molecular
oxygen, comprising a family of radical and non-radical species. A radical species is a free
electron-containing species, including superoxide anion (O2•ˉ) and its conjugated acid
hydroperoxyl radical (HO2•ˉ), hydroxyl (•OH), carbonate (CO3•ˉ), peroxyl (RO2•) and the
alkoxyl radical (RO•). Non-radical species, such as H2O2, hydrogen chloride (HOCl), fatty acid
hydroperoxides (FaOOH), reactive aldehydes and singlet oxygen, can be readily reduced into
free electron-containing species [18]. The reactivity of the different ROS with other compounds
is variable and depends on their processing into more reactive ROS and the diffusion capa‐
bility. It was shown that O2•ˉ and H2O2 do not exhibit strong reactivity with other bio-
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molecules, because they are more stable and can diffuse away from their sites of formation.
Additionally, H2O2 can diffuse through membranes into the extracellular space. In the other
hand, •OH radical is highly reactive and probably accounts for most of the oxidative damage
attributed to ROS. It half-live time is very short, approximately 10-9s, so •OH produced in
vivo reacts close to its side of formation. Iron regulation ensures that there is no free intracellular
iron, however, in vivo, under stress conditions, an excess of superoxide releases “free iron”
form iron-containing molecules. The released Fe2+ can participate in the Fenton reaction,
generating highly reactive hydroxyl radical [19].
These reactive species are generated partly as by-products of cellular metabolism mainly
during mitochondrial electron transport. Evidences implicating mitochondria as the principal
source of ROS were based on the fact that isolated mitochondria can produce O2•ˉ through (1)
auto-oxidation of the flavin component of complex I (NADH hydrogenase) and/or (2) auto-
oxidation of the ubisemiquinone at complex III. During the process of cellular respiration,
electron transfer occurs from NADH and FADH through complexes in the mitochondrial
membrane, leading to a proton gradient, which is necessary for ATP production. Oxygen is
involved as an electron acceptor at the end of the electron transfer in respiration chain. The
electron transfer in respiratory chain is not completely efficient due electrons leakage from
electron transport chain [20]. Approximately 1-3% of the total oxygen consumed in aerobic
metabolism produces O2•ˉ instead of contributing to the reduction of oxygen to water [18]
Direct or indirect damage to mitochondria can lead to electrons leak from electron transport
chain, including oxidative modification of mitochondrial membrane lipids (e. g. cardiolipin),
resulting in mitochondrial outer membrane permeabilization. So O2•ˉ is continuously gener‐
ated mainly at complex I and complex III due to transfer of electrons to molecular oxygen.
Superoxide radical that is produced by complex I is released into the mitochondrial matrix,
whereas complex III forms O2∙- both in the matrix and the inner mitochondrial space [21].
Another major source of ROS is NADPH oxidases, a family of membrane-bound enzymes that
catalyze controlled production of O2•ˉ by coupling NADPH-derived electrons to oxygen. The
NADPH oxidase complex consist of a membrane heterodimeric flavocytochrome (cytochrome
B559) comprising two subunits, gp91phox and p22phox, and four cytosolic proteins, p47phox,
p67phox, p40phox and the small guanosine triphosphate (GTP)-binding protein Rac (1 and 2)
that form a functional complex at the membrane [22,23].
Superoxide can be also produced in the cell through one-electron transfer reactions catalyzed
by a number of enzymes including monoamine oxidase, xantina oxidase, cyclooxygenases,
lipoxygenases and components of the cytochrome P450 system. Peroxisomes are known to
produce H2O2, but not O2•ˉ, under physiologic conditions [24]. Exposition to chemotherapeutic
drugs and UV irradiation also increases the amount of ROS in intracellular milieu [25,26].
Redox homeostasis is determined by the balance between ROS production and detoxification
rates by various antioxidants systems. To maintain intracellular free radicals from many
sources under tight control, cells have developed a series of defense mechanisms against ROS-
induced oxidative stress. The maintenance of intracellular redox state is essential for regulation
of signal transduction because alterations in ROS levels can modify proteins conformation and
consequently their functions. Enzymatic anti-oxidant defenses include superoxide dismutase
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(SOD), glutathione peroxidase (GPx), glutathione reductase (GPx) and catalase (CAT). Non-
enzymatic antioxidants systems are represented by ascorbic acid (Vitamin C), carotenoids,
flavonoids, glutathione (GSH), α-tocopherol (Vitamin E), thioredoxin and other antioxidants.
Superoxide dismutase converts O2•ˉ in the lesser reactive species H2O2 [18,27]. There are three
different SODs, which are involved in superoxide neutralization depending on the site of
superoxide production or diffusion. Cu,Zn-SOD-1 is located in the cytoplasm, MnSOD-2 in
mitochondria and Cu,Zn-SOD3 in the extracellular space [28]. When H2O2 is present in
peroxisomes, it is decomposed to H2O and O2 by catalase. In the cytoplasm, glutathione
peroxidase catalyzes the reduction of H2O2 into H2O via oxidation of glutathione [29, 30, 31].
The tripeptide glutathione is the abundant low-molecular-weight thiol antioxidant, constitut‐
ing with thioredoxin, the major redox buffer of the mammalian cells. Glutathione is present in
reduced (GSH) and in oxidized (GSSH) forms and the reduced form of glutathione is 10- to
100-fold higher than the oxidized form. Glutathione couple (2GSH/GSSG couple) is the main
responsible for the cellular redox homeostasis and therefore is a representative indicator of
oxidative stress [17]. Because cellular glutathione concentration is ~500- to 1000-fold higher
than the other redox regulating proteins, changes in the ratio of reduced to oxidized gluta‐
thione reflect directly intracellular redox alterations [29]. The GSH/GSSG ratio is normally
tightly regulated. Increased ROS levels result in an elevation of GSSH content, which is reduced
to GSH by the NADPH-dependent glutathione reductase as well as thioredoxin/glutaredoxin
systems. So, even in the presence of oxidative stress, the redox homeostasis can be maintained
by increasing glutathione reductase activity or via elimination of GSSG from cells. Glutathione
decreases intracellular ROS levels by acting as cofactor of several detoxifying enzymes against
oxidative stress, e.g, glutathione peroxidase and glutathione transferase; participating in
amino acid transport through the plasma membrane; regenerating vitamin C and E back to
their active forms [32]. Glutathione also modulates the activity of thiol-dependent enzymes
that contain cysteine residues sensitive to redox changes [33].The enzyme γ-glutamylcysteine
synthase (γ-GCS), involved in GSH synthesis, is regulated by ROS levels. Oxidizing conditions
that result in GSH depletion promote a conformation change in γ-GCS, increasing its activity
and GSH synthesis, while physiological GSH concentrations reduces GSH synthesis through
feedback inhibition mechanisms [33].
Peroxiredoxins (Prxs)  are also considered important cell  redox state-regulating enzymes.
Prxs are a family of  peroxidases that  also reduce H2O2  and alkyl  hydroperoxides to the
corresponding water or alcohol. At least six isoforms of human Prxs (Prx1-6) were locat‐
ed in different subcellular compartments, particularly in mitochondria (Prxs3 and 5). Prxs
are  maintained  in  the  reduced  form  by  the  thioredoxin  /thioredoxin  reductase  system
that in conjunction with the GSH/GR system maintains the cellular thiol-disulfide redox
status in the cell [34].
The thioredoxin system comprises thioredoxin (Trx), thioredoxin reductase (TrxR) and
NADPH. Trxs are small redox active proteins (about 12kDa) with a disulfide active site (Trx-
S2) that is reduced to a dithiol (Trx-(SH)2) by thioredoxin reductase (TrxR) using NADPH as
electron donor. Mammalian Trx and TrxR are expressed as isoforms either in the cytosol and
in the nucleus (Trx1 and TrxR1) or in mitochondria (Trx2 and TrxR2); in addition, there are
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testis-specific Trx/TrxR system (Trx3 and TrxR3). Unlike Trx, which is reduced by its own
reductase, glutaredoxins (Grxs) are coupled to GSH/GR. There are four Grx isoforms in
humans, Grx1, Grx-3 and Grx5 primarily cytosolic and Grx2 displays different splice variants,
which are located in mitochondria and nucleus [35].
There is a body of evidence showing the involvement of ROS in regulation of innumerous
signaling pathways that control important biological processes, including migration, differ‐
entiation, proliferation, apoptosis, stress adaptation and gene expression. ROS can modulate
multiple transduction signals by activation of growth factor receptors (e.g. the c-MET, EGF
and PDGF receptor), activation of early growth-related genes such as c-fos and c-jun, altera‐
tions in the activities of protein kinases, oxidative inactivation of phosphatases and activation
of transcription factors [36]. In the other hand, increased ROS levels in tumor cells is influenced
by numerous factors such as disrupted signaling pathways, altered expression of transcription
factors, deregulation of antioxidant enzymes, mitochondrial dysfunction, aberrant cancer cell
metabolism, alteration in proliferation and the acquisition of the metastatic phenotype [9, 37].
Redox  regulation  of  signaling  pathways  occurs  through  modifications  of  redox-reactive
cysteine residues on proteins,  which depend on redox status of the cell  and the concen‐
tration of  ROS. Oxidation of these residues forms reactive sulfenic acid (-SOH) that can
form disulfide bonds with nearby cysteine (-S-S-) or undergo further oxidation to sulfinic
(-SO2H) or sulfonic (-SO3H) acid. These alterations induced by ROS modify the structure
and activity of proteins, regulating their functions. These redox modifications are reversi‐
ble by antioxidants systems, including thioredoxin and peroxiredoxin, contributing to the
modulation of signal transduction [8].
2. Reactive oxygen species in cancer development
Since ROS can act as signaling molecules it is reasonable to think that depending on cell context
ROS could participate in development of innumerous pathologies including cancer. There is
accumulating evidence supporting this view. Levels of ROS are increased in many tumors and
murine and human tumor cells lines, contributing to neoplastic transformation and tumor
progression [13, 38, 39, 40]. By regulating signal transduction pathways, ROS is involved in
the acquisition of cancer hallmarks including self-sufficiency in growth signals, insensitivity
to growth inhibitory (anti-growth) signals, evasion of programmed cell death (apoptosis),
limitless replicative potential, sustained angiogenesis, tissue invasion and metastasis, altered
metabolism and inflammation [40, 41]. The accumulation of ROS participates in the tumor
development of many types of cancer including melanoma, leukemia, gastric, prostate, breast
and colon cancer [39, 42, 43, 44, 45].
One of the signaling pathways regulated by ROS that is implicated in oncogenic transformation
is the mitogen-activated protein kinase (MAPK) cascade that consists of four major MAPKs:
the extracellular signal-related kinases (ERK 1/2), the c-Jun N-terminal kinases (JNK), the p38
kinase (p38) and the big MAP kinase 1 (BMK1/Erk5). The apoptosis signal-regulated kinase 1
(ASK1), which regulates the JNK and p38 MAPK pathways, is activated under stress conditions
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by dissociation of the redox protein thioredoxin. ASK1 is activated when ROS oxidize two
cysteine residues in the redox center of thioredoxin, inducing formation of an intramolecular
disulfide bond and triggering this dissociation from ASK1 [8]. Activated p38 negatively
regulates the malignant transformation induced by oncogenic H-Ras by inhibition of ERK
pathway, induction of premature senescence or by cell cycle arrest triggered by p53 [46]. In
fact, it was shown that p38 specifically impairs the malignant transformation induced by
oncogenes that increase ROS levels (including Ras) by triggering apoptosis and decreasing the
accumulation of ROS [47]. MAPK pathways are also activated by the direct inhibition of MAPK
phosphatases by ROS. Downregulation of mitogen-activated protein kinase phosphatase
(MKP)-3, a negative regulator of ERK1/2, was associated with ubiquitination/proteosome
degradation mediated by high intracellular ROS accumulation such as hydrogen peroxide.
The aberrant ERK activation contributes to tumorigenicity and chemoresistance of human
ovarian cancer cells [48].
Another signaling pathway that contributes to malignant phenotype acquisition, participating
in cell survival and proliferation, is the phosphoinositide 3-kinase (PI3K) pathway. Activation
of this signal transduction is regulated by the phosphatase and tensin homology (PTEN)
phosphatase. It was found that PI3K pathway is reversible regulated by the redox status of the
cell by inactivation of PTEN through oxidation of the cysteine located in its catalytic domain [8].
ROS have also been implicated at all stages of the carcinogenic process since are capable of mod‐
ulating gene expression through oxidative DNA damage and epigenetic alterations [38, 50].
ROS-induced DNA damage includes single- or double-stranded DNA breaks, purine, pyrimi‐
dine or deoxyribose modifications and DNA cross-links. DNA damage can result in arrest or in‐
duction of transcription, induction of signal transduction pathways, replication errors and
genomic instability, all of which are associated with tumorigenesis [19, 51]. The most extensive‐
ly studied DNA lesion is 8-OH-G, a potential biomarker of carcinogenesis [50]. This oxidative
DNA lesion was shown to interfere in the binding of methyl binding proteins to 5-methylcyto‐
sines [52], and 8-OH-G located adjacent to the target cytosine can affect the affinity of DNA for
DNMT3A [53]. These data indicate that 8-OH-G may play a role in the formation of aberrant
DNA methylation patterns during tumor formation. Increased Dnmt1 and global DNA meth‐
ylation levels were observed in murine melanocytes submitted to sustained stress condition as‐
sociated  with  malignant  transformation  [38].  Increased  ROS  levels  can  also  induce  the
recruitment of DNMT1 to damaged chromatin where, together with DNMT3B and members of
the Polycomb repressive complex 4, they form a silencing complex in GC-rich areas that might
explain cancer-specific aberrant DNA methylation and transcriptional repression [54]. Oxida‐
tive stress associated with inflammation also triggers redox signaling through inactivation of
HDACs. The reduction of HDAC activity is associated with posttranslational modifications,
such as carbonylation [55]. Together, these data suggest a connection among oxidative stress,
DNA damage, epigenetic alterations and malignant transformation.
Chronic stress conditions in tumor cells are triggered by an imbalance between ROS produc‐
tion and the ability of cells to scavenge these species. Many studies have shown the increase
in Nox expression and activity in transformed cell lines [9, 56, 57]. It was shown that consti‐
tutively activated isoform of p21Ras, H-Rasv12, in NIH-3T3 fibroblasts improved increased
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superoxide anion production by Nox1, and was functionally required for oncogenic Ras
transformation [58]. Mitochondria dysfunction can lead to oxidative stress, which could be
also implicated in cancer development. Besides defects in mitochondrial electron transport
chain and prolonged hypoxia and glucose deprivation, disrupted cell signal transduction can
also increase mitochondrial-derived ROS in cancer cells. In turn, alteration in mitochondrial
bioenergetics modulates signal transduction. It was demonstrated that increased ROS pro‐
duction derived from mitochondria is induced by oncogenic K-Ras and is required to maintain
anchorage-independent cell grow and proliferation [59].
Increased ROS levels in malignant cells can arise also from the alteration or inactivation of the
antioxidant defense system. Low activities of CuZn-SOD, Mn-SOD, CAT and GPxs have been
reported in a variety of transformed and malignant cells compared with their normal coun‐
terparts [19]. Decreased activity and expression of Mn-SOD was reported in melanoma,
colorectal, prostatic and pancreatic carcinomas [19].
However, it is important to note that only under a mild elevation in intracellular O2•ˉ and
H2O2 signaling pathways stimulate proliferation. In the other hand, if the concentration of ROS
in the cells is so high these effects can be completely reversed resulting in oxidative stress and
death. In this way, cancer cells must render the intracellular milieu pro-oxidant, where ROS
has a pro-life role [60], which is supported by the fact that MnSOD acts like a tumor suppressor
gene. Many authors have shown the suppression of malignant phenotype after MnSOD re-
expression [61, 62, 63]. In addition, intracellular O2∙- has the ability to regulate apoptosis
sensitivity to a variety of apoptotic stimulus [12,13]. The inhibitory effect of O2∙- on cell death
signaling can be attributed to caspase proteases, mediators of apoptotic signaling, inactivation
by oxidative modifications [60] and by the increased expression of Bcl-2, which is associated
with a pro-oxidant milieu [64].
3. Melanoma and oxidative stress
Cutaneous melanoma is a highly malignant tumor derived from pigment-producing melano‐
cytes in the epidermis of the skin. Melanocytes are responsible for the synthesis of melanin in
melanosomes, which in turn, is transferred to neighboring keratinocytes where it can protect
DNA from UV radiation damage. Melanocytic transformation is triggered by sequential
accumulation of genetic and epigenetic alterations that driven modifications in several genes
and signaling transduction pathways leading to abnormal proliferation of melanocytes.
Melanoma is one of the most aggressive tumors with a high frequency of metastasis. The
incidence and mortality rates of malignant melanoma have increased in the past few decades
particularly in Europe and the United States. Although, the etiology of melanoma is not
completely known, several molecular and cellular mechanisms have been shown to contribute
to melanoma genesis. Chronic stress exposures induced, for example, by solar UV and
inflammation are among risk factors for melanoma development [65,66].
Many authors have shown increased ROS levels in melanoma cells through multiple mecha‐
nisms [9, 12, 57]. It was also demonstrated that the ability of melanocytes and melanoma cells to
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respond to oxidative stress is different. While melanocytes have the capability of suppressing
increased ROS levels, melanoma cells are unable to do that [67]. This redox imbalance has a cen‐
tral role in melanoma genesis. One of the reasons is that melanoma cells show decreased antiox‐
idant capability characterized by reduced catalase,  glutathione-S-transferase and MnSOD
enzymatic activity and low levels of glutathione [68, 69], characterizing an aberrant redox state.
Moreover, melanoma cells have constitutive abnormalities in their melanosomes [70]. More im‐
portantly, it was found that melanoma cells have increased superoxide anion and decreased
hydrogen peroxide levels leading to an establishment of a pro-oxidant intracellular milieu and
the activation of redox-sensitive transcription factors that enhance the aggressiveness seen in
melanoma cells characterized by high proliferative rate and drug resistance [60].
Besides genetic alterations found in melanoma caused by UV, the involvement of ROS in
epigenetic alterations was also described in melanoma cells. Increased Dnmt1 and global DNA
methylation levels was observed in murine melanocytes submitted to sustained stress
condition associated with malignant transformation [38]. The treatment of cells with super‐
oxide anion scavenger abrogated the increase of both Dnmt1 and global DNA methylation
level (unpublished results).
4. UV radiation, its connection with oxidative stress and melanoma
development
Circumstantial and direct evidences show ultraviolet radiation (UVR) as major environmental
risk factor for melanoma formation. One of the evidences is the fact that melanoma incidence is
higher in population with light skin types [71]. Skin types depend on melanin production and
there are two types of melanin, eumelanin and pheomelanin. People with light skin have more
pheomelanin than eumelanin and it has been shown that eumelanin confers more protection
against malignant melanoma [72, 73]. Melanin is an important chromophore in the skin which
is able to absorb UVR, visible light and scavenge molecular oxygen and hydroxyl radicals, pro‐
tecting DNA from adducts formation and breaks [4]. In addition, melanoma from sun-exposed
areas has different gene mutations than melanoma from unexposed skin areas, suggesting the
existence of a particular pathway in melanoma genesis associated with UV radiation [65].
Ultraviolet radiation is subdivided into long wavelength UVA, shorter UVB and shortest UVC.
UVC is normally absorbed by ozone at atmosphere and generally does not reach human skin.
UVB is absorbed by cells located at outermost layer of epidermis and can be directly absorbed
by keratinocytes DNA, causing its damage by producing photoproducts such as cyclobutane
pyrimidine dimmers [74]. Additionally, UVB can affect DNA indirectly through oxidative
stress generation [75]. In other way, UVA radiation can penetrate deeper into skin and, in
addition to be absorbed by keratinocytes, is also absorbed by melanocytes, dermal fibroblasts
and other cell types [76]. UVA comprises the majority of UV radiation that reaches earth’s
surface (95%) and is poorly directly absorbed by DNA, but can indirectly affect DNA by
causing reactive oxygen species (ROS) increase and oxidative stress [77]. Oxidative stress can
The Role of Oxidative Stress in Melanoma Development, Progression and Treatment
http://dx.doi.org/10.5772/54937
89
lead to single and double strand DNA breaks, DNA adducts formation, as well lipids and
protein peroxidation.
The specific contribution of UVB and UVA radiation to melanocytes malignant transformation
is questionable because the majority of in vivo and in vitro studies focus on UVB radiation.
Several studies in mice that develop malignant melanoma show a role of UVB in melanoma
genesis, in contrast to this, the role of UVA is less clear. It has been demonstrated that UVB
can activate an important differentiation and proliferation signaling pathway, the MAPK
pathway, leading to AP1 translocation to nucleus [2]. AP-1 results from heretodimerization of
c-Fos and c-Jun proteins, and this complex is important for proper induction of many genes
involved in cellular damage protection and repair against ROS damage. This transcriptional
factor can operate as an oncogene and it has been related with tumor drug resistance [78, 79].
Additionally, Ming and co-workers [81] showed that UVB radiation induces PTEN down
regulation through ERK and AKT pathway activation. The phosphatase and tensin homolog
PTEN is an important tumor suppressor gene that negatively regulates PI3K/AKT pathway
and its loss is related with many tumors, including melanoma [81, 82, 83]. In contrast with
these studies, Kabuyama and colleagues showed in 2001 that while c-Jun is activated in cells
irradiated with UVB, ERK activation occurs at same cells only after UVA irradiation [2].
Interestingly, treatment with antioxidants was able to reverse such activations.
When compared to UVB, there are fewer studies showing long-wave UVA radiation role in
skin cancer, including melanoma. Recent study in mice did not show an induction of melanoma
by a single UVA dose [84]. Nevertheless, there are circumstantial evidences suggesting UVA
role in melanoma formation once it gets through clothes in greater quantities than UVB and it
comprises the majority of UV radiation. Moreover, UVA, like mentioned before, can penetrate
deeper into skin than UVB. It has been shown that high UVA dose causes loss of reduced
glutathione and reduces plasma membrane stability in human melanocytes [85]. Glutathione
is an important cell antioxidant and loss of its reduced state may reflect the oxidative pressure
within this melanocytes as well the plasma membrane stability, once oxidative stress can cause
lipid peroxidation. In opposite way to this effect of UVA on melanocytes, this has only been
shown before in keratinocytes after UVB irradiation [85]. In addition, a recent work showed
an alternative role of melanin in mitochondrial DNA damage only during UVA irradiation,
not UVB, providing evidences for dual role of melanin as both protector and damage agent
[86]. The accumulation of mitochondrial DNA (mtDNA) mutations, through oxidative stress
mechanisms, has been proposed to contribute to carcinogenic and aging process in many
tissues, including skin [76, 86].
Regarding the link between UV radiation and oxidative stress in melanoma, it is important to
mention the fact that both UVA and UVB irradiation can induce nitric oxide synthases (NOS)
expression at skin [87, 88, 89]. Warren and colleagues showed, for example, that an intradermal
injection of L-NAME (NOS inhibitor) prevented erythema caused by UV radiation exposition
in rats [87]. In addition, nitric oxide in combination with superoxide anion can form peroxyni‐
trite, which leads to lipids and proteins peroxidation. Additionally, peroxynitrite might oxidize
tetrahydrobiopterin (BH4) NO syntases’ cofactor, what could cause NOS uncoupling. A critical
aspect of NOS function is the requirement for the cofactor BH4, its absence destabilize NOS,
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which becomes “uncoupled”. Uncoupled NOS produces superoxide anion instead of nitric ox‐
ide [12]. NOS-dependent superoxide formation has central role in the pathology of vascular
diseases like diabetes, hypertension and atherosclerosis, but less is known about this phenom‐
enon in cancer [90, 91]. Nevertheless, results from our group showed for the first time the in‐
volvement of the uncoupled eNOS in the generation of superoxide in melanoma genesis [12].
As showed, a potential causative role of ultraviolet radiation in oxidative stress and melanoma
genesis has been investigated; however, more studies are necessary to fully understand this
association.
5. UV-induced inflammation, immunosuppression and melanoma
The exposure of skin to UV irradiation results in increased blood flow, infiltration by macro‐
phages and neutrophils, as well higher levels of nitric oxide and prostaglandins [87, 92]. This
phenomenon is clinically observed as inflammation. Other UV-induced mediators such as
tumor necrosis factor (TNF) and interleukin-1α (IL-1α) also contribute to inflammation. The
recruited inflammatory cells produce ROS that, like mentioned before, drive damage to lipids,
proteins and DNA. This damage could lead to genetic and epigenetic alterations and contribute
to cancer development [38, 93, 94]. ROS and NO can be associated with all steps of tumor
progression, causing oncogene activation, tumor suppressor inhibition through mutations or
aberrant epigenetic modifications, angiogenesis, local invasion and metastasis [95].
Another feature of UV radiation is the fact that it can cause local and systemic immunosup‐
pression on skin. The precise mechanism is not fully elucidated, but DNA damage is regarded
as fundamental inciting event, which leads to depletion of Langerhans cells from epidermis,
interfering with antigen recognition [96, 97]. It was observed that immunosuppression induced
by UVA radiation diminishes immune surveillance and allows cutaneous melanoma devel‐
opment in transgenic mice [84]. Some additional evidences suggest that NO might be involved
in passing a “migration signal” to the Langerhans cells that stimulates them to migrate and
leave epidermis [98]. In this way, nitrosative stress could be involved both in inflammation
and immunosuppression mechanisms linked with carcinogenesis.
6. The role of NADPH oxidase enzymatic complex in melanoma genesis
Melanoma cells spontaneously generate ROS and present alteration in NOX expression. NOX
family, that comprises NOX1, NOX2 (also called gp91), NOX3, NOX4 and NOX5, consists of
catalytic subunit of NADPH oxidase enzymatic complex, one of cells’ superoxide anion sour‐
ces, as mentioned before. The active form of this multi-protein complex is also normally com‐
posed by transmembrane p22phox and cytosolic proteins, p40phox, p46phox, p67phox and Rac. It has
been observed that while melanoma cells present NOX2, p22phox, p67phox and NOX4 expression,
epidermal melanocytes express only p22phox and NOX4 [99]. Moreover, NOX4, that does not
present Rac cytosolic subunit, was found up regulated in several melanoma cell lines and it
The Role of Oxidative Stress in Melanoma Development, Progression and Treatment
http://dx.doi.org/10.5772/54937
91
seems to be important to regulation of G2-M cell cycle progression [57]. Interestingly, Govin‐
darajan and co-workers [9] showed that AKT signaling is responsible by NOX4 overexpression
in melanoma cell line WM35. These authors also observed that these events seem to be necessa‐
ry to conversion of melanoma with radial growth to melanoma with vertical growth behavior.
In addition to NOX4 role in melanoma, recent research paper showed increased NOX1 protein
level and activity in melanoma cell lines compared to melanocytes. The same work showed that
NOX1 overexpression increases melanoma cells invasion on matrigel and stable clones overex‐
pressing Nox1 exhibited epithelial-mesenchymal transition [100].
There are few studies about NOX role in melanoma and more studies in this area may elucidate
how NADPH oxidases might regulate specific signaling pathways during melanocyte
malignant transformation and melanoma progression.
7. Mitochondria dysfunction as a ROS source in melanoma and therapeutic
target
Recently,  the  role  of  mitochondrial  functions,  such  as  redox  regulation  and  oxidative
phosphorylation  in  melanoma  progression  has  become  to  be  elucidated.  It  was  shown
that dysfunctional mitochondria affect melanoma cell survival and death and drug resist‐
ance [101]. Tumor cells normally produce ATP via glucose metabolism with concomitant‐
ly  decrease  in  ATP  production  by  oxidative  phosphorylation  [102].  Unlike  most  tumor
cells, melanoma cells rely more on oxidative phosphorylation than glycolysis to produce
ATP.  Compared with solid tumor xenografts,  human melanoma xenografts  have one of
the highest  rates  of  oxygen consumption,  a  surrogate  marker  of  oxidative  phosphoryla‐
tion [101, 103]. Moreover, non-glycolytic metabolic sources, such as the Krebs cycle, occur
more frequently in melanoma cells compared with melanocytes [104]. It was also shown
that a particular group of patients with advanced melanoma utilize oxidative phosphory‐
lation for energy production in addition to glycolysis [105]. Consequently, the mitochon‐
dria of melanoma cells generate high levels of ROS. These features make mitochondria a
potential chemotherapy target in melanoma. In fact,  it  was shown that the drug Elesclo‐
mol, that alter redox balance and induce oxidative stress, lead to melanoma cells apopto‐
sis  by  inhibiting  oxidative  phosphorylation  through  down  regulation  of  proteins  from
electron  respiratory  chain.  In  addition,  it  was  also  demonstrated  that  melanoma  cells
with high levels of lactate dehydrogenase (LDH) (***--q), with characterizes ATP produc‐
tion  mainly  by  glucose  metabolism,  are  more  resistant  to  Elesclomol  [101].  Analysis  of
patients  with  normal  lactate  LDH versus  patients  with  high serum LDH levels  showed
that the increase in LDH levels is a prognostic factor for metastatic melanoma [106].
8. Melanin: A pro-oxidant molecule contributing to melanoma genesis
In normal melanocytes, melanin is generated from the successive oxidation of tyrosine by
tyrosinase in sub organelles called melanosomes to protect DNA, including mitochondrial
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DNA, from UV radiation-induced damage [86]. Moreover, melanin neutralizes the inflamma‐
tory response to radiation and acts like an antioxidant, suppressing superoxide anion, singlet
oxygen and hydrogen peroxide [107]. However, in melanoma cells, melanogenesis itself is a
source of ROS and oxidative stress because of malformed melanosomes and melanin synthesis
disruption [108]. Therefore, depending on the melanin type and redox intracellular state,
melanin can play a dual role, both as a photoprotector and as a photosensitizer [86]. In
melanoma cells, melanosomes are poorly compartmentalized, with malformed or twinned
membranes, occlusions within the melanin and evident fragments outside of melanosome
[109]. The structural differences between melanosomes from melanocyte and melanoma cells
are significant, as melanosomal compartmentalization protects the cell from the highly reactive
small-molecules catechols that are generated as by products during melanogenesis [108].
Ultrastructural studies of human melanosomes also indicate that melanocytes generally have
fewer melanosomes than malignant melanoma [110]. Melanin deregulation renders it a pro-
oxidant with ability to increase ROS levels and damage DNA [111]. In addition, melanin
exposition to radiation also renders it pro-oxidant [107]. It is important to note that disturbed
melanin synthesis and chronic oxidative stress are present in dysplastic nevi, indicating that
the switch of melanin to a pro-oxidant state occurs early in melanoma development [112].
Melanins are naturally associated with a number of metal ions and have the capability to
accumulate metals. However, oxidized melanin has high affinity for metal ions in vivo and the
binding of metal ions alters dramatically chemical properties of melanin, increasing it sus‐
ceptibility to further oxidation and the rate of melanin bleaching [113]. Therefore, it was
suggested that metals ions are associated to melanin conversion from a normal reducing status
to a pro-oxidant state. The binding of divalent zinc or cooper to melanin increases the capability
of melanin to react with oxygen by redox cycling and induces the increase in superoxide and
hydroxyl radicals [113]. There are several studies implicating heavy metal ions, including zinc,
cooper and cadmium, in the pathogenesis of melanoma [112, 114]. In fact, melanoma tumors
accumulate high concentrations of Cu and other metals in comparison with melanocytes,
which induce oxidative stress [115]. Moreover, Cu is a critical cofactor for the enzyme tyrosi‐
nase and is found in abundance in melanosomes from melanocytes and melanoma cells [107].
It was shown that the pro-oxidant state of melanin can be a selective target in melanoma. The
treatment of melanoma cells with Zn and Cu dithiocarbamate complexes, which are known
to increase the uptake of metal ions into the cell, augmented the redox cycling of melanin and
the oxidative stress, leading melanoma cells to apoptosis. Interestingly, the treatment was less
toxic to melanocytes [113].
Melanin synthesis is regulated mainly by the alpha-melanocyte stimulating hormones (α-
MSH), which bind to the melanocortin 1 receptor (MC-1R) and activate the cAMP pathway,
which in turn, triggers its downstream effector molecules Protein Kinase A (PKA) and cAMP-
Responsive Element Binding (CREB) transcription factors to up-regulate the expression of mi‐
crophtalmia-associated  transcription  factor  (MITF).  MITF  induces  the  transcription  of
tyrosinase, the rate-limiting enzyme in the synthesis of melanin [116]. Recently, it was shown
that melanin synthesis is regulated by Nox4-induced ROS in a feedback mechanism regulated
by MITF signaling pathway in melanoma cells [37]. The expression of Nox4 and ROS produc‐
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tion was increased by α-MSH and was dependent of MITF signaling. Expression silencing of
Nox4 gene increased melanin formation through MITF and tyrosinase activation upregulation,
unraveling a novel negative regulatory mechanism of pigmentation in melanoma cells. This
could be an adaptive mechanism of melanoma cells submitted to chronic stress condition to
maintain redox homeostasis: decreasing oxidative stress by inhibiting the synthesis of pro-oxi‐
dant melanin.
9. Uncoupled endothelial nitric oxide synthase as a superoxide anion
source: Its role in melanocyte transformation and melanoma progression
There is a lot of evidence showing the involvement of inducible nitric oxide synthase (iNOS)
in melanoma development. Its strong association with poor patient survival seems to indicate
that iNOS is a molecular marker of poor prognosis or a putative target for therapy. All these
studies show the role of nitric oxide, a free radical produced by NOS, in proliferation and
apoptosis [118, 119]. Recently, the role of NO derived from eNOS in melanoma induced by
chronic stress was shown [117]. In fact, eNOS-/- mice are resistant to tumor development [120,
121]. However, NOS can be also a source of superoxide anion [10, 11].
It has been extensively demonstrated that uncoupled NOS can generate superoxide, which has
a central role in the pathogenesis of vascular diseases, such as diabetes, hypertension and
atherosclerosis. NOS are homodimeric oxidoreductases that catalyze NO production from L-
arginine guanidine nitrogen using molecular oxygen. The NOS reductase domain generates
electron that flow from NADPH through FAD and FMN flavins and are transferred to the
oxidase domain of the other monomer in which L-arginine oxidation occurs at the heme group
in the active site. A critical aspect of NOS function is the requirement of the cofactor tetrahy‐
drobiopterin (BH4). In its absence, NOS dimerization is lost and NOS catalytic activity becomes
uncoupled. In this state, NADPH oxidation and molecular oxygen reduction are uncoupled
from L-arginine hydroxylation and nitric oxide (NO) formation. However, electron transfer
from NADPH to molecular oxygen is not inhibited, resulting in superoxide production [10, 11].
An in vitro murine melanocyte malignant transformation model was developed in our
laboratory after submitted a non-tumorigenic melanocyte lineage, melan-a, to a chronic
stressful condition [122], which resulted in the establishment of pre-malignant and melanoma
cell lines. It was demonstrated that along tumor progression increased superoxide and
decreased NO levels were produced. The treatment with L-sepiapterin, a BH4 precursor,
decreased superoxide and increased NO levels in melanoma cells [12]. The abrogation of
superoxide anion levels rendered melanoma cells less anoikis-resistant. More importantly, L-
NAME, a NOS inhibitor that decreases superoxide anion levels, impaired the acquisition of a
malignant phenotype by melan-a that was subjected to a sustained stressful condition [12,
38]. Moreover, the expression of GTP cyclohydrolase I, the rate-limiting enzyme in the
synthesis of BH4, is decreased in melanoma cells (unpublished results). Together, these data
show that the superoxide production by eNOS uncoupling may be important for melanoma
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cells survival and melanocyte malignant transformation. The possible use of BH4 as a chemo‐
preventive agent for melanoma development is under investigation in our laboratory.
10. Redox signaling in melanoma
The appropriate proceeding of tumor cells exposed to ROS is associated with activation of
different signaling pathways that in turn regulate transcriptional changes that allow cells to
respond and adapt to oxidative stress for maintenance of homeostasis. These alterations are
regulated by redox sensors such as apurinic/apyrimidinic endonuclease (APE-1/Ref-1). APE/
Ref-1 is a point of convergence for various redox-sensitive signals as well as being important
in DNA repair. Many studies demonstrated that many survival, proliferation and anti-
apoptotic signaling pathways are activated by APE/Ref-1–mediated transcription factors, such
as AP-1, NF-κB, HIF-1α and p53, whose regulation occurs in both a redox-dependent and a
redox-independent manner [36]. Elevated APE/Ref-1 was associated with decreased intracel‐
lular ROS levels as well as reduced oxidative DNA-damage lesions. However, the prolonged
activation of APE/Ref-1 induced by a sustained stress condition, switches the cellular signaling
to proliferation and apoptosis resistance. It was shown that increased expression of APE/Ref-1
and increased ROS levels play a role in malignant transformation by increasing anchorage-
independent growth and colony formation [123]. Moreover, knockdown of APE/Ref-1 was
shown to efficiently induce apoptosis, sensitization, or both to chemical treatments [124]. It is
also well documented that elevated APE/Ref-1 is associated with chemo- and radio-resistance
in a number of cellular systems. Recently, this group also suggested that APE/Ref-1 is involved
in the regulation of metastasis produced by melanoma cells [125]. These studies suggested
that, as an adaptive response induced by APE/Ref-1, this transcription factor besides efficiently
repairs oxidative DNA damage, also regulates redox-sensitive signaling such as AP-1 and NF-
κB, which are involved in melanoma genesis. In fact, it was demonstrated the increased
expression of APE/Ref-1 in melanoma specimens and cells, which is predominantly found in
the nucleus and contributed to the binding and activation of AP-1 and NF-κB [123, 124].
Therefore, all these properties make APE/Ref-1 a promise target for melanoma therapy.
A signaling pathway disrupted in melanoma cells that is redox-sensitive is the Ras/
BRAF/MEK/ERK [126]. We have observed that activation of Ras-ERK signal transduction in
melan-a melanocytes during loss of integrin-mediated cell-matrix contact is regulated and
regulates superoxide anion levels which is associated with global DNA hypermethylation
(unpublished results). This aberrant signaling seems to have a significant impact in melanoma
genesis since the malignant transformation was drastically compromised when melan-a
melanocytes were pre-treated with superoxide scavenger.
Another pathway involved in melanoma progression that is responsive to alterations in redox
homeostasis is p38 signal pathway. In melanocytes exposed to oxidative stress and UV-
irradiation, p38 is activated and induces the expression of p16INK4A, which in turn decreases
ROS levels [127]. It can be a mechanism by which the tumor suppressor gene p16INK4A protects
melanocytes against malignant transformation. According to this point, it was shown by many
authors that induction of apoptosis in melanoma cells is dependent on p38 activation [128, 129].
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11. Antioxidant therapy for melanoma
Many cancer types have some imbalance in physiologic antioxidant levels compared with the
cell of origin like was mentioned before in this chapter [130]. Moreover, levels of anti-oxidant
enzymes and non-enzymatic antioxidants such as catalase, MnSOD, glutathione (GSH),
vitamins E, C and A are all typically decreased in tumors [131]. Although mutations in MnSOD
gene have been demonstrated in some melanomas, the other antioxidant enzymes were found
with high activity in this type of cancer cells [61, 131].
The redox imbalance found in melanoma cells is implicated in the malignant phenotype of
these cells, characterized by abnormal proliferation, apoptosis resistance and metastasis
capability through regulation of key signaling pathways. These observations support the
notion that melanoma could be targeted using antioxidant therapy.
One of antioxidants, approved by Food and Drug Administration (FDA) and used to treat
pulmonary fibrosis, is N-acetylcysteine (NAC) [132]. Studies in mouse showed that orally
administrated NAC reduced UV-induced squamous carcinoma [133]. Moreover, Cotter and
colleagues showed that NAC protects melanocytes from oxidative stress and delays UV-
induced melanoma growth in mice [134]. In addition, other studies observed that topical NAC
reduced UV-mediated GSH depletion and peroxide induction in normal human skin [135,
136]. The antioxidant vitamin E delays or reduces UV-induced skin carcinogenesis in mice,
through reduction in DNA damage, immunosuppression or both [137]. Other epidemiologic
studies showed that increased vitamins D and C intakes have some influence in melanoma
prevention [14].
As mentioned above, the redox transcription factor sensor APE/Ref-1 has a potential as a target
for the development of a new chemopreventive agent against cancer. Using docking-and-
scoring technology and virtual screening, resveratrol was found to dock in one of the two drug-
treatable pockets located in the redox domain of APE/Ref-1 [124]. The inhibitory effects of
resveratrol on APE/Ref-1 occurred mostly through its redox-regulating functions and might
be the principal role on its pharmacological activities, which are implicated in the reduced
AP-1 and NF-κB activities in many human cancers [138]. In studies using human melanoma
cells, resveratrol was shown to inhibit, in a dose-dependent manner, the APE1/Ref-1-mediated
DNA-binding of AP-1. Resveratrol was also shown to inhibit APE1/Ref-1 endonuclease
activity and render melanoma cells more sensitive to treatment with the alkylating agent
dacarbazine [124]. More recently, a small molecule called E3330 was developed and showed
strong inhibition of APE/Ref-1 in vitro [139]. The use of E3330 inhibited the interaction between
retinoic acid receptor and its DNA response elements, which is redox-sensitive and mediated
by APE/Ref-1, and increased the differentiation and apoptosis of myeloid leukemia cells
induced by retinoic acid [140]. Therefore, these compounds may represent a novel class of
anticancer agents and promising candidates for in vivo studies.
Although promising, treatment of melanoma with antioxidants has not yet achieved the
desired results. One hypothesis is that antioxidants can be used as chemopreventive drugs,
since the main role of ROS seems to be in the early progression of melanoma, when the tumor
is fully installed.
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12. Conclusion
Melanocytes are naturally exposed to oxidative stress due to UV, UV-associated inflammation
and metal ions accumulation. However, melanocytes have a great capability to regulate their
redox homeostasis due increased antioxidant activity and redox buffer characteristic of
melanin. The disruption of redox regulation in melanocytes is not clear, but seems to be a
consequence of many factors, including decreased of antioxidant enzymes expression and
activity as MnSOD and glutathione levels, the switch of melanin to a pro-oxidant molecule
and disturbance of signaling pathways that control melanocytes proliferation. Therefore,
increased ROS levels found in melanoma cells are not a simple consequence of altered
metabolism, but instead seem to have a central role in melanocyte malignant transformation
and in abilities acquired during tumor progression as chemoresistance. The establishment of
a pro-oxidant microenvironment also contributes to melanoma progression, implicating
inflammatory cells as essential sources of ROS. Many mechanisms are associated with ROS
accumulation in melanoma cells, including mitochondria dysfunction, increased NADPH
oxidase activity and NOS uncoupling. ROS are implicated in regulating several biological
processes by acting downstream important signaling pathways. Moreover, ROS regulate gene
expression by genetic and epigenetic alterations. Although ROS are implicated in all stages of
melanocyte malignant transformation, the uses of antioxidants as therapeutic strategies have
not been successful. However, its use as a chemopreventive strategy has been shown to be
efficient. Hence, efforts should be concentrated in the studies of the use of antioxidants as
chemopreventive drugs for melanoma.
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